Pharmacokinetic Study of Spironolactone 25 mg, 50 mg and 100 mg Tablets
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
Objective is to investigate pharmacokinetics and to estimate the level of dose linearity of
spironolactone and its metabolites canrenone and 7α-thiomethylspirolactone from
Spironolactone 25 mg, 50 mg and 100 mg Tablets